Anticancer Targets in the Glycolytic Metabolism of Tumors: a Comprehensive Review

Overview

Journal Front Pharmacol

Date 2011 Sep 10

PMID 21904528

Citations 209

Authors

Paolo E Porporato

Suveera Dhup

Rajesh K Dadhich

Tamara Copetti

Pierre Sonveaux

Affiliations

Soon will be listed here.

Abstract

CANCER IS A METABOLIC DISEASE AND THE SOLUTION OF TWO METABOLIC EQUATIONS: to produce energy with limited resources and to fulfill the biosynthetic needs of proliferating cells. Both equations are solved when glycolysis is uncoupled from oxidative phosphorylation in the tricarboxylic acid cycle, a process known as the glycolytic switch. This review addresses in a comprehensive manner the main molecular events accounting for high-rate glycolysis in cancer. It starts from modulation of the Pasteur Effect allowing short-term adaptation to hypoxia, highlights the key role exerted by the hypoxia-inducible transcription factor HIF-1 in long-term adaptation to hypoxia, and summarizes the current knowledge concerning the necessary involvement of aerobic glycolysis (the Warburg effect) in cancer cell proliferation. Based on the many observations positioning glycolysis as a central player in malignancy, the most advanced anticancer treatments targeting tumor glycolysis are briefly reviewed.

Citing Articles

Optimization of central carbon metabolism by Warburg effect of human cancer cell improves triterpenes biosynthesis in yeast.

Lin X, An T, Fu D, Duan S, Jin H, Wang H Adv Biotechnol (Singap). 2025; 1(4):4.

PMID: 39883335 PMC: 11727583. DOI: 10.1007/s44307-023-00004-6.

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.

Disruption of the Physical Interaction Between Carbonic Anhydrase IX and the Monocarboxylate Transporter 4 Impacts Lactate Transport in Breast Cancer Cells.

Combs J, Murray A, Lomelino C, Mboge M, Mietzsch M, Horenstein N Int J Mol Sci. 2024; 25(22.

PMID: 39596062 PMC: 11593560. DOI: 10.3390/ijms252211994.

Neuronal extracellular vesicles influence the expression, degradation and oligomeric state of fructose 1,6-bisphosphatase 2 in astrocytes affecting their glycolytic capacity.

Hajka D, Budziak B, Rakus D, Gizak A Sci Rep. 2024; 14(1):20932.

PMID: 39251668 PMC: 11385182. DOI: 10.1038/s41598-024-71560-7.

PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer.

Ogunleye A, Gayen N, Rauth S, Marimuthu S, Nimmakayala R, Alsafwani Z Cancer Metab. 2024; 12(1):26.

PMID: 39242538 PMC: 11380429. DOI: 10.1186/s40170-024-00354-2.

References

Rojas Ayala F, Rocha R, Carvalho K, Carvalho A, da Cunha I, Lourenco S . GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules. 2010; 15(4):2374-87. PMC: 6257354. DOI: 10.3390/molecules15042374. View

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Garcia C, Brown M, Pathak R, Goldstein J . cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J Biol Chem. 1995; 270(4):1843-9. DOI: 10.1074/jbc.270.4.1843. View

Grandori C, Cowley S, James L, Eisenman R . The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol. 2000; 16:653-99. DOI: 10.1146/annurev.cellbio.16.1.653. View

Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H . Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun. 2001; 287(2):562-7. DOI: 10.1006/bbrc.2001.5627. View

Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K . Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate. 2010; 70(13):1388-94. PMC: 4142700. DOI: 10.1002/pros.21172. View

Haber R, Rathan A, Weiser K, Pritsker A, Itzkowitz S, Bodian C . GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 1998; 83(1):34-40. DOI: 10.1002/(sici)1097-0142(19980701)83:1<34::aid-cncr5>3.0.co;2-e. View

Lin C, Liu J, Chow J, Liu C, Liu H . Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. Anticancer Drugs. 2006; 18(2):161-70. DOI: 10.1097/CAD.0b013e3280109424. View

Xu C, Lo A, Yammanuru A, Tallarico A, Brady K, Murakami A . Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology. PLoS One. 2010; 5(3):e9625. PMC: 2835754. DOI: 10.1371/journal.pone.0009625. View

10.

DeBerardinis R, Cheng T . Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2009; 29(3):313-24. PMC: 2809806. DOI: 10.1038/onc.2009.358. View

11.

Gambhir S . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002; 2(9):683-93. DOI: 10.1038/nrc882. View

12.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

13.

Bristow R, Hill R . Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008; 8(3):180-92. DOI: 10.1038/nrc2344. View

14.

Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon M . Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol. 2003; 63(1):81-6. DOI: 10.1023/a:1023756707900. View

15.

Okar D, Lange A . Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes. Biofactors. 1999; 10(1):1-14. DOI: 10.1002/biof.5520100101. View

16.

MARKERT C, Shaklee J, Whitt G . Evolution of a gene. Multiple genes for LDH isozymes provide a model of the evolution of gene structure, function and regulation. Science. 1975; 189(4197):102-14. DOI: 10.1126/science.1138367. View

17.

Rho M, Kim J, Jee C, Lee Y, Lee H, Kim M . Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines. Anticancer Res. 2007; 27(1A):251-8. View

18.

Ebert B, Firth J, Ratcliffe P . Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem. 1995; 270(49):29083-9. DOI: 10.1074/jbc.270.49.29083. View

19.

Shackelford D, Vasquez D, Corbeil J, Wu S, Leblanc M, Wu C . mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci U S A. 2009; 106(27):11137-42. PMC: 2708689. DOI: 10.1073/pnas.0900465106. View

20.

Perez de Heredia F, Wood I, Trayhurn P . Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes. Pflugers Arch. 2009; 459(3):509-18. DOI: 10.1007/s00424-009-0750-3. View